Verve Therapeutics Statistics
Total Valuation
SLTTF has a market cap or net worth of 22.18 million. The enterprise value is 797.54 million.
Market Cap | 22.18M |
Enterprise Value | 797.54M |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 80.56M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.43% |
Shares Change (QoQ) | +7.07% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 79.44M |
Valuation Ratios
Price/FFO Ratio | n/a |
Price/AFFO Ratio | n/a |
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.16 |
PB Ratio | 0.60 |
P/TBV Ratio | 0.60 |
P/FCF Ratio | 2.99 |
P/OCF Ratio | 1.08 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.30, with an EV/FCF ratio of 107.52.
EV / Earnings | -2.58 |
EV / Sales | 5.69 |
EV / EBITDA | 16.30 |
EV / EBIT | 16.51 |
EV / FCF | 107.52 |
Financial Position
The company has a current ratio of 0.06, with a Debt / Equity ratio of 20.29.
Current Ratio | 0.06 |
Quick Ratio | 0.03 |
Debt / Equity | 20.29 |
Debt / EBITDA | 16.08 |
Debt / FCF | 101.81 |
Interest Coverage | 0.76 |
Financial Efficiency
Return on equity (ROE) is -162.05% and return on invested capital (ROIC) is 2.98%.
Return on Equity (ROE) | -162.05% |
Return on Assets (ROA) | 2.82% |
Return on Invested Capital (ROIC) | 2.98% |
Return on Capital Employed (ROCE) | 28.02% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.13 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, SLTTF has paid 482,137 in taxes.
Income Tax | 482,137 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +71.35% in the last 52 weeks. The beta is 0.91, so SLTTF's price volatility has been similar to the market average.
Beta (5Y) | 0.91 |
52-Week Price Change | +71.35% |
50-Day Moving Average | 0.36 |
200-Day Moving Average | 1.40 |
Relative Strength Index (RSI) | 44.72 |
Average Volume (20 Days) | 8,267 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SLTTF had revenue of 134.60 million and -309.70 million in losses. Loss per share was -3.85.
Revenue | 134.60M |
Gross Profit | 55.38M |
Operating Income | 46.37M |
Pretax Income | -309.22M |
Net Income | -309.70M |
EBITDA | 46.96M |
EBIT | 46.37M |
Loss Per Share | -3.85 |
Balance Sheet
The company has 10.84 million in cash and 755.22 million in debt, giving a net cash position of -744.38 million.
Cash & Cash Equivalents | 10.84M |
Total Debt | 755.22M |
Net Cash | -744.38M |
Net Cash Per Share | n/a |
Equity (Book Value) | 37.23M |
Book Value Per Share | 0.46 |
Working Capital | -656.95M |
Cash Flow
In the last 12 months, operating cash flow was 20.60 million and capital expenditures -13.19 million, giving a free cash flow of 7.42 million.
Operating Cash Flow | 20.60M |
Capital Expenditures | -13.19M |
Free Cash Flow | 7.42M |
FCF Per Share | n/a |
Margins
Gross margin is 41.15%, with operating and profit margins of 34.45% and -230.09%.
Gross Margin | 41.15% |
Operating Margin | 34.45% |
Pretax Margin | -229.73% |
Profit Margin | -230.09% |
EBITDA Margin | 34.89% |
EBIT Margin | 34.45% |
FCF Margin | 5.51% |
Dividends & Yields
SLTTF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.43% |
Shareholder Yield | n/a |
Earnings Yield | -1,395.98% |
FCF Yield | 33.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |